The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for NICO sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
NICO is a medical equipment company that develops technologies and devices for minimally invasive neurosurgery. Its major brands include BrainPath, NICO meniGLIDE, NICO SecureHOLD Retractors, and NICO Myriad. Nico technologies have application in multiple surgical areas like MIPS, endoscopic, transnasal, brain biopsy and open craniotomy. The company sells its products through distributors in the US, Canada, UK, Ireland, Germany, Slovenia, Spain, Portugal, Australia, Singapore, and Malaysia. Nico is headquartered in Indianapolis, Indiana, the US.
The key metrics of NICO related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As NICO is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as NICO.
For a detailed understanding of the performance of NICO, buy the report here.